SCHEMBL12909354

SCHEMBL12909354

CO[n+]1ccc(C(=O)c2cc(C)c(C)cc2NS(=O)(=O)c2ccc(C)cc2)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
CYP1A2 P05177 2/20 0.53
HPGD P15428 2/20 0.53
HSD17B10 Q99714 1/20 0.53
CYP2C9 P11712 4/20 0.48
LMNA P02545 3/20 0.47
HTT P42858 2/20 0.47
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
CCR9 P51686 3/20 0.45
GAA P10253 1/20 0.44
GFER P55789 1/20 0.44
CYP2C19 P33261 1/20 0.44
FFAR4 Q5NUL3 2/20 0.43
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
TCF4 P15884 1/20 0.41
CTNNB1 P35222 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12909349 0.86 ALDH1A1 (0.54) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL11930669 0.86 ALDH1A1 (0.56) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL12909483 0.82 ALDH1A1 (0.48) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL12909350 0.81 ALDH1A1 (0.50) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL12909355 0.78 CYP2C9 (0.47) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL11930656 0.78 CCR9 (0.57) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL12909353 0.78 LMNA (0.50) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL12909348 0.77 FFAR4 (0.48) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL10248298 0.76 LMNA (0.56) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9
SCHEMBL11930653 0.76 CCR9 (0.62) ALDH1A1CYP1A2HPGDHSD17B10CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021523-A1 ARYL SULFONAMIDES CHEMOCENTRYX, INC. (US) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021523-A1 ARYL SULFONAMIDES CCR9, CCR1, CCR2 ALDH1A1 1655/4885CYP1A2 1855/4885HPGD 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.